Investigators conducted a large retrospective study to determine whether high-dose methotrexate prophylaxis affected incidence of CNS relapse in patients with DLBCL at ultra-high risk for CNS relapse.

Please provide your email address to receive an email when new articles are posted on . Patients with psoriasis taking methotrexate were 2.8 times more likely to develop nonmelanoma skin cancer than ...

Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...

Patients with arthritis have reported being unable to get their methotrexate refills after the Supreme Court decision to strike down Roe v Wade. After the U.S. Supreme court overruled Roe v Wade last ...

Patients with rheumatoid arthritis who are treated with methotrexate appear to have an elevated risk of developing melanoma compared with the general population. Melanoma, the most serious type of ...

The immunosuppressive drug methotrexate (MTX) can be linked to an elevated risk of three types of skin cancer, a new study by University of Gothenburg researchers shows. Patients receiving the drug ...

Add Yahoo as a preferred source to see more of our stories on Google. (Reuters) - The U.S. Food and Drug Administration (FDA) reported on Tuesday Accord Healthcare has resumed manufacturing of ...

Liver cancer is one of the most prevalent and deadly types of cancer worldwide. Most patients are diagnosed at an advanced stage, which leaves them with few treatment options. Unfortunately, the first ...

(Reuters) - The U.S. Food and Drug Administration said on Friday it is seeking new suppliers to ease shortages of methotrexate, one of the most commonly used cancer drugs, building on its push to ...

The site is operated with the financial support of the Ministry of Digital Development, Communications and Mass Media of the Russian Federation. The information resource uses recommendation ...

Nov 7 (Reuters) - The U.S. Food and Drug Administration (FDA) reported on Tuesday Accord Healthcare has resumed manufacturing of methotrexate, one of the most commonly used cancer drugs, amid ongoing ...